Fig. 4From: Pyruvate kinase M2 and the mitochondrial ATPase Inhibitory Factor 1 provide novel biomarkers of dermatomyositis: a metabolic link to oncogenesisDiagnostic performance of PKM2 in inflammatory myopathies. ROC was plotted to describe PKM2 performance characteristics in a 32 subject cohort. 95% IC 0.961–1.000; P = 0.000 AUC, area under the curveBack to article page